Description

Technical Parameters

Introduction

peptides

product-1400-1400

Products Description

### Selank peptide: a systematic review

Selank (chemical name: Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide originally developed by Russian scientists based on the natural immunomodulatory peptide **tuftsin**. It is designed to enhance central nervous system function while combining anti-anxiety, anti-depressant and immunomodulatory properties. Selank exerts multi-target effects by regulating neurotransmitter systems (such as serotonin, GABA and dopamine) and immune factors (such as cytokines), and is considered a new type of neuromodulator. The following is a systematic introduction from six categories: **structural characteristics, pharmacological effects, physicochemical properties, application areas, safety** and **comparative analysis**.

### 1. Structural characteristics and chemical modification

#### 1. **Amino acid sequence and structure**

The amino acid sequence of Selank is **Thr-Lys-Pro-Arg-Pro-Gly-Pro**, which belongs to the short-chain peptide class. Its core structure is derived from tuftsin (Thr-Lys-Pro-Arg), but it is modified by adding a **Pro-Gly-Pro** tail chain, which significantly enhances metabolic stability and blood-brain barrier penetration.

#### 2. **Chemical modification and optimization**

- **Enhanced stability**: By introducing proline (Pro) and glycine (Gly) residues, enzymatic hydrolysis is reduced and the half-life is extended (about **2-4 hours**).

- **Hydrophilicity optimization**: The positively charged residues of lysine (Lys) and arginine (Arg) give it good water solubility, suitable for subcutaneous or intravenous injection.

#### 3. **Molecular weight and chemical formula**

- Molecular weight: **883.98 g/mol**

- Chemical formula: **C₃₅H₆₂N₁₂O₁₀**

### 2. Pharmacological effects and mechanisms

#### 1. **Antianxiety and antidepression**

- **GABA system regulation**: Selank reduces neuronal overexcitation and relieves anxiety symptoms by enhancing GABAergic neurotransmission.

- **Serotonin level regulation**: Clinical studies have shown that it can increase brain 5-HT (serotonin) levels and improve the behavioral performance of depression model animals.

- **Clinical trial data**: In a double-blind trial, Selank significantly reduced the Hamilton Anxiety Rating Scale (HAMA) score, which is equivalent to benzodiazepines, but is not addictive.

#### 2. **Cognitive enhancement and neuroprotection**

- **BDNF upregulation**: Promotes brain-derived neurotrophic factor (BDNF) expression, supports neuronal survival and synaptic plasticity.

- **Memory consolidation**: Animal experiments have shown that Selank can improve hippocampal-dependent memory task performance, especially in chronic stress models.

#### 3. **Immunomodulation**

- **Cytokine balance**: Inhibits pro-inflammatory factors (such as IL-6, TNF-α) while enhancing the secretion of anti-inflammatory factors (such as IL-10).

- **Innate immune activation**: Enhances antiviral and anti-tumor immune responses by stimulating macrophage and NK cell activity.

### 3. Physical and chemical properties

#### 1. **Basic properties**

- **Appearance**: White to off-white crystalline powder, no visible impurities.

- **Solubility**: Soluble in water (>50 mg/mL), saline and PBS buffer, slightly soluble in ethanol, insoluble in lipid solvents.

- **Stability**: Lyophilized powder can be stored for 2 years at -20°C; solution form needs to be refrigerated away from light (2-8°C) to avoid repeated freezing and thawing.

#### 2. **Spectral characteristics**

- **UV absorption**: Maximum absorption wavelength is about **280 nm** (contributed by the side chains of arginine and lysine).

- **Fluorescence characteristics**: No autofluorescence, suitable for fluorescent labeling research.

#### 3. **Chromatographic behavior**

- **HPLC analysis**: Typical retention time is **8-10 minutes** (C18 column, acetonitrile/water gradient elution).

- **Purity standard**: The purity of commercially available Selank is usually ≥98%, and the impurities are mainly truncated peptides or oxidation products.

### 4. Application fields

#### 1. **Clinical medicine**

- **Anxiety treatment**: As an alternative to benzodiazepines, it is used for generalized anxiety disorder (GAD) and post-traumatic stress disorder (PTSD).

- **Adjunctive treatment of depression**: Combined with SSRIs can accelerate symptom relief.

- **Neurodegenerative diseases**: Alzheimer's disease models show that it can reduce Aβ plaque deposition.

#### 2. **Scientific research fields**

- **Neuropharmacology tools**: Used to study the cross-regulatory mechanism of the GABAergic system and the immune-neural axis.

- **Behavioral model construction**: Simulate anxiety/depression phenotypes in rodents and test intervention strategies.

#### 3. **Functional applications**

- **Cognitive enhancer**: Improve attention and working memory in healthy people (further clinical verification is required).

- **Immunoadjuvant therapy**: Combined with chemotherapy or antiviral therapy to reduce immunosuppressive side effects.

### 5. Safety and side effects

#### 1. **Toxicology data**

- **Acute toxicity**: LD₅₀ (rat, intravenous injection) > 500 mg/kg, indicating high safety.

- **Long-term toxicity**: No organ pathological changes were found after 6 consecutive months of administration.

#### 2. **Side effects**

- **Common reactions**: Redness and swelling at the injection site, transient dizziness (incidence <5%).

- **Rare reactions**: Allergic reactions (skin test required in advance).

#### 3. **Drug interactions**

- **Synergistic effects**: Combination with SSRIs or benzodiazepines may enhance efficacy.

- **Contraindications**: Use with caution in patients with severe hepatic and renal insufficiency.

### 6. Comparative analysis with similar peptides

|-------------------|------------------|------------------|------------------|

| **Clinical indications** | Anxiety, depression | Stroke recovery, glaucoma | Immunodeficiency

### 7. Future research directions

1. **New drug delivery system**: Develop nasal spray or transdermal patch to improve bioavailability.

2. **Peptide analog design**: Enhance stability through D-amino acid substitution or cyclization structure.

3. **In-depth analysis of the mechanism**: Use single-cell sequencing technology to explore its effects on specific neural circuits.

### Conclusion

Due to its multi-target effects, high safety and wide therapeutic potential, Selank has become a hot topic in neuropeptide research. With the development of precision medicine, its application prospects in individualized treatment are worth looking forward to. In the future, large-scale clinical trials need to be further carried out to explore its synergistic effects with other biological agents.